Abbott Laboratories moved -0.1% this afternoon session, trading between a high of $96.54 and a low of $93.755 per share. Yesterday the stock finished at $95.56 per share, compared to an average analyst target price of $119.22.
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. The large-cap medical/dental instruments company is based in the United States, and over the last twelve months it has returned a dividend yield of 2.1%. Abbott Laboratories has trailing twelve months earnings per share (EPS) of 2.93, which at today's prices amounts to a price to earnings (P/E) ratio of 32.6.
Based on its expected future earnings growth, the company has a price to earnings growth (PEG) ratio of -10.32. Usually a PEG ratio between 0 and 1 indicates a potentially undervalued company.
Overview of the Company's Gross Margins:
Date Reported | Revenue ($ k) | Cost of Revenue ($ k) | Gross Margins (%) | YoY Growth (%) |
---|---|---|---|---|
2023-02-17 | 43,653,000 | -19,142,000 | 56 | 0.0 |
2022-02-18 | 43,075,000 | -18,537,000 | 56 | 0.0 |
2021-02-19 | 34,608,000 | -15,003,000 | 56 | -5.08 |
2020-02-21 | 31,904,000 | -13,231,000 | 59 | 3.51 |
2019-02-22 | 30,578,000 | -12,706,000 | 57 | 3.64 |
2018-02-16 | 27,390,000 | -12,409,000 | 55 |
Abbott Laboratories's 56.5% average gross margins are thinner than the 57.74% average of the Medical Instruments & Supplies industry, implying that the firm might be lacking in competitivity.